Janssen S

No ORCID on file · 1 paper in corpus
2020
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] ·doi:10.1007/s00066-020-01629-5

PurposeTo assess the outcome of prostate cancer (PCa) patients diagnosed with oligorecurrent disease and treated with a first and a second PSMA (prostate-specific membrane antigen ligand) PET(positron-emission tomography)-directed radiother…